Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||
|---|---|---|---|---|---|---|
| LHLONGEVITY | +1.79% | +3.76% | +0.41% | +1.44% | +10.18% | +12.80% |
| KFHHCARE-A | +3.09% | +5.02% | +8.12% | +7.02% | +16.41% | +15.55% |
| TGHRMF-A | +2.05% | +4.81% | +9.19% | +10.32% | +21.09% | +21.08% |
| BCARERMF | +1.81% | +5.38% | +6.86% | +7.46% | +18.07% | +20.13% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| KFHHCARE-A | TGHRMF-A | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 7.97% | 10.15% |
 Johnson & Johnson | 6.28% | 6.99% |
 ABBVIE | 7.27% | 5.07% |
 Merck & | 5.28% | 4.22% |
 Unitedhealth Group | 3.29% | 3.88% |
 Thermo Fisher | 4.58% | 2.94% |
 AstraZeneca | 4.08% | 2.32% |
| Only in KFHHCARE-A | ||
 Novartis | 4.48% | N/A |
 Abbott Laboratories | 2.89% | N/A |
 Danaher | 2.89% | N/A |
| Only in TGHRMF-A | ||
 Amgen | N/A | 3.34% |
 Roche | N/A | 2.70% |
 Novartis AG Registered Shares | N/A | 2.41% |
26 Mar 2026 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| TGHRMF-A | +21.08% | 16.41% | 1.28 |
| BCARERMF | +20.13% | 16.70% | 1.21 |
| KFHHCARE-A | +15.55% | 15.90% | 0.98 |
| LHLONGEVITY | +12.80% | 22.39% | 0.57 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | LHLONGEVITY | KFHHCARE-A | TGHRMF-A | BCARERMF |
|---|---|---|---|---|
Fund details | ||||
| Fund size | 75.68 million | 896 million | 138 million | 8,627 million |
| Inception date | 27 Mar 2026 | 1 Feb 2019 | 1 Sep 2015 | 19 May 2015 |
| Master fund | Tema Oncology ETF | JPMorgan Funds - Global Healthcare Fund | กองทุนที่ลงทุนหลายกอง (ISHARES GLOBAL HEALTHCARE, State Street Health Care Select Sector SPDR, ISHARES BIOTECHNOLOGY) | Wellington Global Health Care Equity Fund |
| Dividend policy | Does not pay | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | 7 | 7 | 7 | 7 |
| Hedging policy | Hedged at the manager's discretion | Almost fully hedged | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 79.91% | 100.28% | 90.96% | 45.53% |
Minimum purchase and redemption | ||||
| First purchase | 1,000 THB | 500 THB | 1,000 THB | 500 THB |
| Subsequent purchase | 100 THB | 500 THB | 1,000 THB | 500 THB |
| Redemption (amount) | No minimum | 500 THB | No minimum | No minimum |
| Redemption (units) | No minimum | 50 units | No minimum | No minimum |
| Balance (amount) | 100 THB | No minimum | No minimum | No minimum |
| Balance (units) | No minimum | 50 units | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | 15:30 | 15:30 | 15:30 | 15:30 |
| Redeem before | 15:30 | 14:30 | 15:30 | 15:30 |
| Redemption paid | T+2 | T+4 | T+3 | T+4 |
